This study provides a basis for understanding the diverse pathways targeted by somatic mutation in mucinous tumors of the ovary, although further functional work is required to elucidate the role of novel, less commonly affected genes with conflicting roles in the literature, such as ELF3 and KLF5. This evidence concerns the gene KLF5 and ovarian mucinous neoplasm.